Domicile
Reels
Groupes
Pages
Plus
Groupes Pages Evènements Blogs Financement
Se connecter S’enregistrer
Mode nuit
What Are the Key Challenges Facing the AAV Vector-based Gene Therapy Market?
Despite its promise, the AAV vector-based gene therapy market faces significant challenges. High treatment costs—often exceeding millions of dollars per patient—raise access and reimbursement concerns. Payers are scrutinizing value, and outcomes-based payment models are being explored. The adeno-associated virus vector-based gene therapy market also faces immunogenicity issues....
0 Commentaires ·0 Parts ·130 Vue ·0 Aperçu
Connectez-vous pour aimer, partager et commenter!